home / stock / rfl / rfl news


RFL News and Press, Rafael Holdings Inc. Class B From 08/05/19

Stock Information

Company Name: Rafael Holdings Inc. Class B
Stock Symbol: RFL
Market: NYSE
Website: rafaelholdings.com

Menu

RFL RFL Quote RFL Short RFL News RFL Articles RFL Message Board
Get RFL Alerts

News, Short Squeeze, Breakout and More Instantly...

RFL - LipoMedix Appoints New Members to Board of Directors and Creates New Executive Committee

Jerusalem, Aug. 05, 2019 (GLOBE NEWSWIRE) --   LipoMedix Pharmaceuticals Ltd. , a clinical and development-stage company focused on the development of an innovative, safe and effective cancer therapy based on liposome delivery, today announced the addition of  Miranda J. Toledan...

RFL - Rafael Pharmaceuticals Launches Clinical Trial Web Portal "Rafael Trial Connect"

Newark, NJ, Aug. 05, 2019 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals Inc. (“Rafael” or the “Company”), a leader in the growing field of cancer metabolism-based therapeutics, announced today the launch of Rafael Trial Connect , a web portal available on the...

RFL - Rafael Pharmaceuticals Announces Expansion into Austria, South Korea and Spain of Pivotal Phase 3 Trial (ARMADA 2000) of CPI-613® (devimistat) in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML)

Cranbury, NJ, Aug. 01, 2019 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals Announces Expansion into Austria, South Korea and Spain of Pivotal Phase 3 Trial (ARMADA 2000) of CPI-613 ® (devimistat) in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) CRANBURY, N.J., Augu...

RFL - David A. Polinsky, Esq Appointed to the Board of Directors of Innovative Food Holdings, Inc.

BONITA SPRINGS, Fla., July 30, 2019 (GLOBE NEWSWIRE) -- Innovative Food Holdings, Inc. (OTCQB: IVFH), (“IVFH” or “the Company”) an interconnected platform of specialty food companies that provides chefs and consumers direct access  to the highest quality spe...

RFL - Rafael Pharmaceuticals Announces Expansion into Israel of Pivotal Phase 3 Trial (AVENGER 500) of CPI-613®? (devimistat) in Combination with Modified FOLFIRINOX as First-Line Treatment for Patients with Metastatic Pancreatic Cancer

Cranbury, NJ, July 18, 2019 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals, Inc. (“Rafael” or the “Company”), a leader in the growing field of cancer metabolism-based therapeutics, today announced the expansion of its Phase 3 clinical trial for patients with meta...

RFL - Rafael Holdings: Vulnerable To Correction

Editor's note: Seeking Alpha is proud to welcome Reformer Capital as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to SA Essential. Click here to find out more » Rafael Holding...

RFL - Microcaps mostly among midday movers

Gainers:  MDJM (NASDAQ: MDJH ) +48% . Oasmia Pharmaceutical AB (NASDAQ: OASM ) +27% . Xcel Brands (NASDAQ: XELB ) +20% . Alithya Group (NASDAQ: ALYA ) +17% . Maxar Technologies (NYSE: MAXR ) +16% . Amarin Corporation (NASDAQ: AMRN ) +13% . ReTo Eco-Solutions (NASDAQ: RETO ) +13...

RFL - Healthcare and Tech dominate midday movers

Gainers:  Pyxus International (NYSE: PYX ) +28% . Allergan (NYSE: AGN ) +26% . ENDRA Life Sciences (NASDAQ: NDRA ) +23% . Pier 1 Imports (NYSE: PIR ) +18% . Rafael Holdings (NYSEMKT: RFL ) +16% . Riot Blockchain (NASDAQ: RIOT ) +15% . Vislink Technologies (NASDAQ: VISL ) +15% ....

RFL - Rafael Pharmaceuticals Enters into Out-Licensing Agreement with Ono Pharmaceutical to Accelerate Clinical Development and Commercialization of Cancer Drug Candidate CPI-613® (devimistat) in Japan and Other Asian Countries

Cranbury, NJ, June 25, 2019 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals, Inc. (“Rafael” or the “Company”), a leader in the growing field of cancer metabolism-based therapeutics, announced today that it has entered into an out-licensing agreement with Ono Pha...

RFL - Sanjeev Luther, President and CEO of Rafael Pharmaceuticals, Named Finalist for The 2019 EY Entrepreneur Of The Year® Award in New Jersey

Newark, NJ, June 06, 2019 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals Inc. (“Rafael” or the “Company”), a leader in the growing field of cancer metabolism-based therapeutics, has announced that Sanjeev Luther, President and Chief Executive Officer of Rafael, i...

Previous 10 Next 10